These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 28074593)

  • 1. Microtubule-associated protein 1B: Novel paraneoplastic biomarker.
    Gadoth A; Kryzer TJ; Fryer J; McKeon A; Lennon VA; Pittock SJ
    Ann Neurol; 2017 Feb; 81(2):266-277. PubMed ID: 28074593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paraneoplastic autoimmunity and small-cell lung cancer: Neurological and serological accompaniments.
    Zekeridou A; Majed M; Heliopoulos I; Lennon VA
    Thorac Cancer; 2019 Apr; 10(4):1001-1004. PubMed ID: 30810271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ANNA-3 anti-neuronal nuclear antibody: marker of lung cancer-related autoimmunity.
    Chan KH; Vernino S; Lennon VA
    Ann Neurol; 2001 Sep; 50(3):301-11. PubMed ID: 11558786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody types and IgG subclasses in paraneoplastic neurological syndromes.
    Greenlee JE; Boyden JW; Pingree M; Brashear HR; Clawson SA; Keeney PM
    J Neurol Sci; 2001 Mar; 184(2):131-7. PubMed ID: 11239946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Purkinje cell antibody (PCA-2): marker of lung cancer-related neurological autoimmunity.
    Vernino S; Lennon VA
    Ann Neurol; 2000 Mar; 47(3):297-305. PubMed ID: 10716248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome.
    Pittock SJ; Kryzer TJ; Lennon VA
    Ann Neurol; 2004 Nov; 56(5):715-9. PubMed ID: 15468074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SOX1 antibodies in sera from patients with paraneoplastic neurological syndromes.
    Stich O; Klages E; Bischler P; Jarius S; Rasiah C; Voltz R; Rauer S
    Acta Neurol Scand; 2012 May; 125(5):326-31. PubMed ID: 21751968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of paraneoplastic myelopathy associated with anti-CV2/CRMP5 antibodies with small-cell lung cancer].
    Sato C; Kano T; Yabe I; Sasaki H
    Rinsho Shinkeigaku; 2020 Aug; 60(8):560-564. PubMed ID: 32641628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paraneoplastic anti-neuronal nuclear IgG autoantibodies (type I) localize antigen in small cell lung carcinoma.
    Kiers L; Altermatt HJ; Lennon VA
    Mayo Clin Proc; 1991 Dec; 66(12):1209-16. PubMed ID: 1660950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SOX-1 autoantibodies in patients with paraneoplastic neurological syndromes.
    Tschernatsch M; Gross O; Kneifel N; Kaps M; Blaes F
    Autoimmun Rev; 2009 Jun; 8(7):549-51. PubMed ID: 19393214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leucine Zipper 4 Autoantibody: A Novel Germ Cell Tumor and Paraneoplastic Biomarker.
    Dubey D; Kryzer T; Guo Y; Clarkson B; Cheville JC; Costello BA; Leibovich BC; Algeciras-Schimnich A; Lucchinnetti C; Hammami MB; Knight AM; Howe C; Lennon VA; McKeon A; Pittock SJ
    Ann Neurol; 2021 May; 89(5):1001-1010. PubMed ID: 33583072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neural autoantibody clusters aid diagnosis of cancer.
    Horta ES; Lennon VA; Lachance DH; Jenkins SM; Smith CY; McKeon A; Klein C; Pittock SJ
    Clin Cancer Res; 2014 Jul; 20(14):3862-9. PubMed ID: 24833664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraneoplastic anti-Purkinje and type I anti-neuronal nuclear autoantibodies bind selectively to central, peripheral, and autonomic nervous system cells.
    Altermatt HJ; Rodriguez M; Scheithauer BW; Lennon VA
    Lab Invest; 1991 Oct; 65(4):412-20. PubMed ID: 1921331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neurologic paraneoplastic syndrome with anti-CV2/CRMP5 antibodies revealing a small cell lung cancer. Effectiveness of the lung cancer treatment].
    Rosencher L; Maisonobe T; Lavole A; Milleron B; Ferroir JP
    Rev Neurol (Paris); 2012 Apr; 168(4):371-4. PubMed ID: 22387203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune Vestibulocerebellar Syndromes.
    Narayan RN; McKeon A; Fife TD
    Semin Neurol; 2020 Feb; 40(1):97-115. PubMed ID: 31958862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purkinje cell cytoplasmic antibody type 1 (anti-Yo) autoimmunity in a child with Down syndrome.
    Philipps G; Alisanski SB; Pranzatelli M; Clardy SL; Lennon VA; McKeon A
    JAMA Neurol; 2014 Mar; 71(3):347-9. PubMed ID: 24424854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pitfalls in the diagnosis of autoantibodies associated with paraneoplastic neurologic disease.
    Sillevis-Smitt P; Manley G; Moll JW; Dalmau J; Posner JB
    Neurology; 1996 Jun; 46(6):1739-41. PubMed ID: 8649581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuronal Na+/K+ ATPase is an autoantibody target in paraneoplastic neurologic syndrome.
    Scharf M; Miske R; Heidenreich F; Giess R; Landwehr P; Blöcker IM; Begemann N; Denno Y; Tiede S; Dähnrich C; Schlumberger W; Unger M; Teegen B; Stöcker W; Probst C; Komorowski L
    Neurology; 2015 Apr; 84(16):1673-9. PubMed ID: 25809299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune central nervous system paraneoplastic disorders: mechanisms, diagnosis, and therapeutic options.
    Dropcho EJ
    Ann Neurol; 1995 May; 37 Suppl 1():S102-13. PubMed ID: 8968221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of SKOR2 IgG as a novel biomarker of paraneoplastic neurologic syndrome.
    Rezk M; Pittock SJ; Kapadia RK; Knight AM; Guo Y; Gupta P; LaFrance-Corey RG; Zekeridou A; McKeon A; Dasari S; Mills JR; Dubey D
    Front Immunol; 2023; 14():1243946. PubMed ID: 37795104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.